Comparisons between glucose analogue 2-deoxy-2-(18F)fluoro-D-glucose and 18F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions

doi:10.4329/wjr.v8.i2.200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10586)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

528

WORD

350

HTML

4567

Figures (1-3)

319

Tables (1-3)

280

Sum=6044

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

511

Download

1598

Sum=2109

Publishing Process of This Article

Item

Count

Browse

854

Download

1579

Sum=2433

Feb 28, 2016 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Radiol. Feb 28, 2016; 8(2): 200-209
Published online Feb 28, 2016. doi: 10.4329/wjr.v8.i2.200

Table 1 Patient characteristics (n = 45)

Demography
Age (yr)	61 ± 10
Stage at diagnosis
I	5
II	21
III	14
IV	5
Histology
Ductal	35
Lobular	8
Other	2
Tumor receptor (+/-/unknown)
Estrogen receptor	39/2/4
PgR	29/11/5
c-erb B2	14/24/7
Site of metastatic disease other than bone
Lung	27%
Liver	20%
Lymph nodes	30%
Systemic therapy
First-line	81%
Second-line	62%
Third-line	36%
Bisphosphonates	22%
Follow-up (mean 28 mo range 22-39)
Patients with disease progression	58%
Patients dead from disease	30%

Citation: Capitanio S, Bongioanni F, Piccardo A, Campus C, Gonella R, Tixi L, Naseri M, Pennone M, Altrinetti V, Buschiazzo A, Bossert I, Fiz F, Bruno A, DeCensi A, Sambuceti G, Morbelli S. Comparisons between glucose analogue 2-deoxy-2-(¹⁸F)fluoro-D-glucose and ¹⁸F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. World J Radiol 2016; 8(2): 200-209
URL: https://www.wjgnet.com/1949-8470/full/v8/i2/200.htm
DOI: https://dx.doi.org/10.4329/wjr.v8.i2.200